iRhythm Holdings, Inc. IRTC

Latest FY: 2025 Healthcare Medical Devices
Market Price $126.40
Market Cap $4.05B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑26.2% YoY
$747.14M
3-Yr CAGR: 22.1%
Net Income ↑60.7% YoY
-$44.55M
Net Margin: -6.0%
Free Cash Flow ↑213.0% YoY
$34.52M
FCF Yield: 0.85%
EPS (Diluted) ↑61.7% YoY
$-1.39
Basic: $-1.39
Return on Equity Efficiency
-29.2%
ROA: -205.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (IRTC)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $64.1M $43.2M $-20.9M $-3.95 $-16.7M $-19.4M
FY 2017 $98.5M +53.7% $70.8M $-29.4M -40.7% $-1.30 +67.1% $-14.9M $-18.5M +4.8%
FY 2018 $147.3M +49.5% $108.7M $-48.3M -64.1% $-2.02 -55.4% $-29.1M $-34.2M -85.4%
FY 2019 $214.6M +45.7% $162.1M $-54.6M -13.0% $-2.16 -6.9% $-21.9M $-42.3M -23.6%
FY 2020 $265.2M +23.6% $194.9M $-43.8M +19.7% $-1.58 +26.9% $-13.8M $-27.3M +35.5%
FY 2021 $322.8M +21.7% $213.6M $-101.4M -131.3% $-3.46 -119.0% $-37.8M $-65.8M -141.0%
FY 2022 $410.9M +27.3% $281.6M $-116.2M -14.6% $-3.88 -12.1% $-23.0M $-52.8M +19.7%
FY 2023 $492.7M +19.9% $331.8M $-123.4M -6.2% $-4.04 -4.1% $-50.1M $-90.5M -71.3%
FY 2024 $591.8M +20.1% $407.5M $-113.3M +8.2% $-3.63 +10.1% $3.4M $-30.6M +66.3%
FY 2025 $747.1M +26.2% $527.2M $-44.6M +60.7% $-1.39 +61.7% $80.9M $34.5M +213.0%
$

Valuation

Market Price $126.40
Market Cap $4.05B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 27.19
FCF Yield 0.85%
Dividend Yield N/A
Shares Outstanding 32,862,400
%

Profitability & Margins

Gross Margin 70.57%
Operating Margin -7.68%
Net Margin -5.96%
Return on Equity (ROE) -29.17%
Return on Assets (ROA) -205.66%
Asset Turnover 34.49x
Revenue 3-Yr CAGR 22.05%
🛡️

Financial Health & Liquidity

Current Ratio 0.17
Cash Ratio 1.83
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $236.01M
Total Debt N/A
Book Value / Share $4.65
💧

Cash Flow Efficiency

Operating Cash Flow $80.86M
Capital Expenditures (CapEx) $46.34M
Free Cash Flow $34.52M
OCF / Revenue 10.82%
FCF / Revenue 4.62%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.39
EPS (Basic) $-1.39
Dividends / Share N/A
Book Value / Share $4.65
EPS YoY Growth 61.71%
🏛️

Balance Sheet (FY 2025)

Total Assets $21.66M
Total Liabilities $128.75M
Stockholders' Equity $152.75M
Current Assets $21.66M
Current Liabilities $128.75M